Arkadios Wealth Advisors Has $5.95 Million Stock Holdings in MetLife, Inc. $MET

Arkadios Wealth Advisors grew its stake in MetLife, Inc. (NYSE:MET) by 3.4% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 73,948 shares of the financial services provider’s stock after buying an additional 2,457 shares during the period. Arkadios Wealth Advisors’ holdings in MetLife were worth $5,947,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in MET. North Capital Inc. acquired a new stake in shares of MetLife in the first quarter valued at about $26,000. Quaker Wealth Management LLC increased its stake in shares of MetLife by 198.2% in the second quarter. Quaker Wealth Management LLC now owns 333 shares of the financial services provider’s stock valued at $27,000 after buying an additional 672 shares during the period. Motco increased its stake in shares of MetLife by 105.5% in the first quarter. Motco now owns 413 shares of the financial services provider’s stock valued at $33,000 after buying an additional 212 shares during the period. GFG Capital LLC acquired a new stake in shares of MetLife in the second quarter valued at about $38,000. Finally, Abound Wealth Management increased its stake in shares of MetLife by 652.3% in the second quarter. Abound Wealth Management now owns 489 shares of the financial services provider’s stock valued at $39,000 after buying an additional 424 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Stock Performance

Shares of MetLife stock opened at $78.30 on Thursday. The company has a market cap of $52.07 billion, a PE ratio of 13.27, a price-to-earnings-growth ratio of 0.71 and a beta of 0.86. MetLife, Inc. has a 52 week low of $65.21 and a 52 week high of $89.05. The business has a 50 day moving average price of $80.39 and a 200-day moving average price of $78.53. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57.

MetLife (NYSE:MET) last issued its quarterly earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing analysts’ consensus estimates of $2.32 by ($0.30). The business had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $18.58 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The business’s revenue was down 2.7% compared to the same quarter last year. During the same period in the previous year, the business posted $2.28 earnings per share. Equities analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th will be given a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Tuesday, November 4th. MetLife’s dividend payout ratio (DPR) is presently 38.47%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Keefe, Bruyette & Woods decreased their price target on MetLife from $94.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday, August 11th. Barclays upped their target price on MetLife from $93.00 to $98.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. JPMorgan Chase & Co. upped their target price on MetLife from $86.00 to $95.00 and gave the company an “overweight” rating in a research report on Tuesday, July 8th. Wolfe Research upgraded MetLife to a “strong-buy” rating in a research report on Tuesday, September 16th. Finally, Morgan Stanley upped their target price on MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $95.18.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.